J&J CFO on acetaminophen: ‘There’s no basis to believe it’s dangerous’

Joe Wolk, Johnson & Johnson CFO, joins Yahoo Finance’s Adam Shapiro and Julie Hyman to discuss its fourth-quarter earnings report, talc baby powder, the current controversy around Acetaminophen and why the Johnson & Johnson board will not split its portfolio. …read more

Source:: Yahoo Finance

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.